## 



## 

## 

|Reference and Administrative<br>Details|||
|---|---|---|
|Trustees'<br>Report||2to5|
|Independent<br>Examiner's<br>Report||6to 7|
|Consolidated<br>Statement<br>of Financial|Activities||
|Consolidated<br>Balance Sheet|||
|Balance Sheet||10|
|Consolidated<br>Statement<br>ofCash Flows|||
|Notes to the Financial Statements||12to 25|





## 

## 



## 

## 

## 



## 

## 

## 

## 

## 

## 

## 



## 

## 

## 

## 

## 

## 



## 

## 

## 



## 

## 

## 

## 



## 

## 



## 

## 

## 

|||Total|Recognised<br>G|ains and Loss|<br>es)||
|---|---|---|---|---|---|---|
||||Unrestricted|Restricted|Total|Total|
||||funds|funds|2022|2021|
|||Note|E|f.||F|
|Income and Endowments||from:|||||
|Donations<br>and legacies||2|6,190||6,190|9,626|
|Other trading<br>activities||3|289,426||289,426|202,161|
|Investment<br>income||4|1,614||1,614|224|
|Other income||5||||34,689|
|Total income|||297,230||297,230|246,700|
|Expenditure<br>on:|||||||
|Raising funds|||(217,175)||(217,175)|(178,555)|
|Charitable<br>activities<br>Other expenditure|||(77,563)<br>~(725||(77,563)<br>(725|(109,922)<br>(689|
|Total expenditure|||(295,463)||(295,463|(289,166)|
|Net income/(expenditure)|||1,767||1,767|(42,466|
|Net movement<br>in funds|||1,767||1,767|(42,466)|
|Reconciliation<br>offunds|||||||
|Total funds brought|forward||505,029|440|505,469|547,935|
|Total funds carried|forward|tg|506,796|440|507,236|505,469|





## 

## 

|C|o|nsolidated<br>Salance Sheet a|s at 30Sept|ember 2022||
|---|---|---|---|---|---|
|||||2022|2021|
||||Note|||
|Fixed assets||||||
|Tangible assets|||13|1,059|2,032|
|Current assets||||||
|Stocks<br>Debtors<br>Cash at bank and|in|hand|15|11,628<br>15,565<br>505,948|12,011<br>8,948<br>499,688|
|||||533,141|520,647|
|Creditors: Amounts||falling due within one year|16|(26,964)|(17,210)|
|Net current assets||||506,177|503,437|
|Net assets||||507,236|505,469|
|Funds ofthe group:||||||
|Restricted<br>income|funds|||||
|Restricted<br>funds||||440|440|
|Unrestricted<br>income||funds||||
|Unrestricted<br>funds||||506,796|505,029|
|Total funds|||19|507,236|505,469|





## 

## 

||||||2022|2021|
|---|---|---|---|---|---|---|
|||||Note||f.|
|Fixed assets|||||||
|Investments|||||100|100|
|Current assets|||||||
|Debtors<br>Cash at bank and||in hand||15|74,509<br>439,646|61,423<br>448,972|
||||||514,155|510,395|
|Creditors:|Amounts||falling due within one year|16|(3,540)|(2,520)|
|Net current|assets||||510,615|507,875|
|Net assets|||||510,715|507,975|
|Funds ofthe charity:|||||||
|Restricted|income|funds|||||
|Restricted funds|||||440|440|
|Unrestricted|income||funds||||
|Unrestricted|funds||||510,275|507,535|
|Total funds|||||510,715|507,975|





## 

|Consolidated<br>Statemen|t ofCash F|lows for|the Year En|ded 30Septem|ber<br>2022|
|---|---|---|---|---|---|
|||||2022|2021|
||||Note||f.|
|Cash flows from operating|activities|||||
|Net cash income/(expenditure)||||1,767|(42,466)|
|Adjustments<br>to cash flows|from noncash|items||||
|Depreciation||||1,453|1,446|
|Investment<br>income||||1,614|224|
|||||1,606|(41,244)|
|Working capital adjustments||||||
|Decrease/(increase)<br>in stocks<br>Increase<br>in debtors<br>Increase/(decrease)<br>in creditors|||15<br>16|383<br>(6,617)<br>9,754|(423)<br>(4,151)<br>451|
|Net cash flows from operating|activities|||5,126|46,269|
|Cash flows from investing<br>activities||||||
|Interest receivable<br>and similar|income||4|1,614|224|
|Purchase oftangible<br>fixed assets|||13|(480)|(978)|
|Net cash flows from investing|activities|||1,134|754|
|Net increase/(decrease)<br>in cash and cash equivalents||||6,260|(47,023)|
|Cash and cash equivalents<br>at|1 October|||499,688|546,711|
|Cash and cash equivalents<br>at|30 September|||505,948|499,688|





## 

## 

## 

## 

## 

## 

## 

## 



## 

## 

## 

## 

## 

## 

## 



## 

## 

## 

## 

## 

## 

## 

## 



## 

## 

## 

|2<br>Income|from donati|ons<br>and legacies||||
|---|---|---|---|---|---|
||||Unrestricted|||
||||funds|Total|Total|
||||General|2022|2021|
||||||E|
|Donations<br>and legacies;||||||
|Donations|and gifts||4,568|4,568|5,514|
|Legacies and funeral||donations|762|762|2,980|
|Income tax and gift aid|||860|860|1,132|
||||6,190|6,190|9,626|



## 

|3<br>Inco|me fro|m othe|r trading activities||||
|---|---|---|---|---|---|---|
|||||Unrestricted|||
|||||funds|Total|Total|
|||||General|2022|2021|
|Trading|income;||||||
|Commercial||trading|operations|288,689|288,689|202,156|
|Events|income;||||||
|Other|events|income||737|737||
|||||289,426|289,426|202,161|





## 

## 

## 

||||Unrestricted||||
|---|---|---|---|---|---|---|
||||funds|Total|Total||
||||General|2022|2021||
||||||F||
|Other|investment|income|1,614|1,614||224|



## 

||||Total|Total|
|---|---|---|---|---|
||||2022|2021|
||||F|F|
|Other operating<br>CJRS income||income||1,082<br>3,931|
|Insurance|payout|||29,676|
|||||34,689|





## 

## 

## 

## 

||||Unrestricted||||
|---|---|---|---|---|---|---|
||||funds|Total||Total|
||||General|2022||2021|
|||||E|||
|Fund-raising|and|publicity|175||175||



## 

|b) Cos|ts oftradin|g<br>activities|||||
|---|---|---|---|---|---|---|
|||||Unrestricted|||
|||||funds|Total|Total|
||||Note|General<br>f|2022|2021|
|Trading|subsidiary|costs|11|217,000|217,000|178,555|
|||||217,000|217,000|178,555|



## 

|7<br>Expen|di|ture<br>on charitable<br>activit|ies|||||
|---|---|---|---|---|---|---|---|
|||||Unrestricted||||
|||||funds|Total||Total|
|||||General|2022||2021|
||||Note|||||
|Support to Patients||||735||735||
|Allocated|support costs|||725||725|689|
|Governance||costs||3,710|3,710||2,520|
|Donations|to YDH NHS Foundation|||||||
|Trust||||73,118|73,118||107,402|
|||||78,288|78,288||110,611|





## 

## 

## 

|Suppo|rt costs allocated|to charitable<br>activities||||||
|---|---|---|---|---|---|---|---|
||||Other|||||
||||support|Total||Total||
|||Basis of|costs|2022||2021||
|||allocation||K||||
|Attend|subscription|100%support|725||725||689|



## 

|||||Unrestricted|||
|---|---|---|---|---|---|---|
|||||funds|Total|Total|
|||||General|2022|2021|
||||||F|f.|
|Independent||examiner fees|||||
||Examination<br>Other fees|ofthe financial statements<br> paid to examiners||1,525<br>2,185|1,525<br>2,185|1,380<br>1,140|
|||||3,710|3,710|2,520|
|9|Net incoming/outgoing||resources||||
|Net incoming/(outgoing)<br>resources for the year include:|||||||



|||2022|2021|
|---|---|---|---|
|Independent<br>Depreciation|examiner's<br>fees<br>offixed assets|3,710<br>1,453|2,520<br>1,446|



## 



## 

## 

## 

## 

## 

|Sbid<br>||i||||
|---|---|---|---|---|---|
|usary<br>Pr||t and Loss||2022|2021|
|Turnover||||288,689|202,156|
|Cost ofsales||||(172,522)|(125,753)|
|Gross profit||||116,167|76,403|
|Other operating||income||347|35,952|
|Administrative|expenses|||(44,478)|(52,802)|
|Net Profit||||72,036|59,553|
|Reserves<br>brought<br>forward||||57,515|59,467|
|Distribution<br>to The League ofFriends ofYeovil Hospitals||||(60,021)|(61,505)|
|Retained<br>in Subsidiary||||||
|The assets and||liabilities ofthe subsidiary|were|2022|2021|
||||||E|
|Fixed assets||||1,059|2,032|
|Current assets||||91,995|70,273|
|Current<br>liabilities||||(23,424)|(14,690)|
|Total net assets||||69,630|57,615|
|Share capital||||100|100|
|Reserves||||69,530|57,515|
|Total equity||||69,630|57,615|





## 

## 

## 

|12Staffcosts|12Staffcosts|12Staffcosts||||
|---|---|---|---|---|---|
|The aggregate<br>payroll costs were as follows:||||||
|||||2022|2021|
||||||f.|
|Staffcosts during the|year were:|||||
|Wages and salaries||||35,615|43,079|
|Staff pensions<br>(defined|contribution)|||1,366|1,360|
|||||36,981|44,439|
|The average<br>number ofpersons<br>employed||during|the year was as follows:|||



## 

## 

|Group||||
|---|---|---|---|
||Fixtures and|Office||
||fittings|equipment|Total|
||||E|
|Cost||||
|At 1 October 2021|13,915|978|14,893|
|Additions<br>Disposals|480<br>559||480<br>~(559|
|At 30September 2022|13,836|978|14,814|
|Depreciation||||
|At 1 October 2021|12,665|196|12,861|
|Charge for the year<br>Eliminated<br>on disposals|1,297<br>559|156|1,453<br>~559|
|At 30September 2022|13,403|352|13,755|
|Net book value||||
|At 30September 2022|433|626|1,059|
|At 30September 2021|1,250|782|2,032|





## 

## 

## 

## 

||Subsidiary||
|---|---|---|
||undertakings|Total|
||E||
|Cost|||
|At 1 October 2021|100|100|
|At 30September 2022|100|100|
|Net book value|||
|At 30September 2022|100|100|
|At 30 September 2021|100|100|



## 

|15Debtors||||||
|---|---|---|---|---|---|
||Group<br>2022|2021|2022|Charity|2021|
||E||||F|
|Prepayments|265|||265||
|Accrued income|375|3|73,384||60,024|
|Other debtors|14,925|8,945||860|1,399|
||15,565|8,948|74,509||61,423|



## 

|16Creditors:|amounts<br>falling|due within one year||||
|---|---|---|---|---|---|
|||Group<br>2022|2021|2022<br>Charity|2021|
|||F|F||F|
|Trade creditors||15,218|8,545|||
|Other taxation|and social|||||
|security||359|668|||
|VAT payable||4,222|2,188|||
|Other creditors||1,241|1,310|||
|Accruals||5,924|4,499|3,540|2,520|
|||26,964|17,210|3,540|2,520|





## 

## 

## 

## 

## 



## 

## 

|Group|||||||
|---|---|---|---|---|---|---|
|||||||Balance at|
|||Balance at||||30|
|||1 October<br>2021<br>f.|Incoming<br>resources<br>E|Resources<br>expended|Transfers|September<br>2022|
|Unrestricted<br>funds|||||||
|General|||||||
|Unrestricted<br>general|||||||
|funds||169,771|297,230|(267,601)|(140,520)|58,880|
|Designated|||||||
|Children's<br>outpatients||300,000|||(150,000)|150,000|
|Breast Cancer Unit|||||100,000|100,000|
|New projects<br>Other designated|funds|35,258||~27,662|150,000<br>40,520|150,000<br>47,916|
|||335,258||(27,862)|140,520|447,916|
|Total unrestricted|funds|505,029|297,230|~(295,463||506,796|
|Restricted funds|||||||
|Chemotherapy<br>unit||66||||66|
|Macmillan<br>unit Barrie|||||||
|Ackland||85||||85|
|Ward 8BDaphne|I Tulk|175||||175|
|Macmillan<br>unit John Hicks||114||||114|
|Total restricted funds||440||||440|
|Total funds|||||||





## 

## 

|Notes to the Financial|Statements<br>for|the Year End|ed 30Septem|ber 2022|
|---|---|---|---|---|
||Balance at 1<br>October 2020|Incoming<br>resources|Resources<br>expended|Balance at 30<br>September<br>2021|
|||||F|
|Unrestricted<br>funds|||||
|General|||||
|Unrestricted<br>general funds|163,246|246,700|(240,175)|169,771|
|Designated|||||
|Children's<br>outpatients<br>Other designated<br>funds|300,000<br>83,624||(48,366)|300,000<br>35,258|
||383,624||48,366|335,258|
|Total unrestricted<br>funds|546,870|246,700|(288,541|505,029|
|Restricted funds|||||
|Chemotherapy<br>unit|66|||66|
|Macmillan<br>unit Barrie Ackland<br>Ward 8BDaphne<br>I Tulk|85<br>175|||85<br>175|
|Mrs H M Ward patients|||||
|vouchers<br>for shop<br>Macmillan<br>unit John Hicks|625<br>114||(625)|114|
|Total restricted<br>funds|1,065||(625|440|
|Total funds|547,935|246,700|(289,166|505,469|





## 

## 

## 

|Group||||||
|---|---|---|---|---|---|
||||||Total funds|
||||Unrestricted||at 30|
||||funds<br>General|Restricted<br>funds|September<br>2022|
||||E|||
|Tangible <br>Current <br>Current||fixed assets<br> assets<br>liabilities|1,059<br>532,701<br>26,964|440|1,059<br>533,141<br>26,964|
|Total net assets|||506,796|440|507,236|
||||||Total funds|
||||Unrestricted||at 30|
||||funds<br>General|Restricted<br>funds|September<br>2021|
|Tangible <br>Current <br>Current|fixed assets<br> assets<br>liabilities||2,032<br>520,207<br>17,210|440|2,032<br>520,647<br>17,210)|
|Total net||assets|505,029|440|505,469|



## 

## 

## 

